Role of sympathetic tone in BSO-induced hypertension in mice

American Journal of Hypertension

Volumn 23, Issue 8, 2010, Pages 882-888

  Rodríguez Gómez, Isabel ^a   Baca, Yolanda ^b   Moreno, Juan M ^a   Wangensteen, Rosemary ^a   Perez Abud, Rocío ^b   Payá, Jorge A ^a   O'Valle, Francisco ^a   Vargas, Félix ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

blood pressure; BSO; hypertension; mice; oxidative stress; sympathetic tone

Indexed keywords

BUTHIONINE SULFOXIMINE; CREATININE; ISOPROSTANE; NORADRENALIN; PENTOLONIUM TARTRATE; PRAZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; GANGLION BLOCKING AGENT; ISOPROSTANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; BRAIN STEM; CONTROLLED STUDY; CREATININE CLEARANCE; EXPERIMENTAL STUDY; GANGLION BLOCK; HEART RATE; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MORPHOLOGY; MOUSE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEINURIA; SYMPATHETIC TONE; URINARY EXCRETION; ADRENERGIC SYSTEM; ANIMAL; CBA MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD PRESSURE; BUTHIONINE SULFOXIMINE; GANGLIONIC BLOCKERS; HEART RATE; HYPERTENSION; ISOPROSTANES; MALE; MICE; MICE, INBRED CBA; OXIDATIVE STRESS; PENTOLINIUM TARTRATE; PRAZOSIN; RECEPTORS, ADRENERGIC, ALPHA-1; SYMPATHETIC NERVOUS SYSTEM; ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS;

EID: 77955770308     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.90     Document Type: Article

References (37)

1. DiBona GF. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 2002; 11:197-200.
2. Fujita T, Henry WL, Bartter FC, Lake CR, Delea CS. Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med 1980; 69:334-344.
3. Koepke J P, DiBona G F. High sodium intake enhances renal nerve and antinatriuretic responses to stress in spontaneously hypertensive rats. Hypertension 1985; 7:357-363.
4. Ono A, Kuwaki T, Kumada M, Fujita T. Differential central modulation of the baroreflex by salt loading in normotensive and spontaneously hypertensive rats. Hypertension 1997; 29:808-814.
5. Leenen FH, Ruzicka M, Huang BS. The brain and salt-sensitive hypertension. Curr Hypertens Rep 2002; 4:129-135.
6. Wangensteen R, O'Valle F, Del Moral R, Vargas F, Osuna A. Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats. Med Sci Monit 2002; 8:BR378-BR384.
7. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000; 36:142-146.
8. Campese VM, Ye S, Zhong H, Yanamadala V, Ye Z, Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am J Physiol Heart Circ Physiol 2004; 287:H695-H703.
9. Zanzinger J, Czachurski J. Chronic oxidative stress in the RVLM modulates sympathetic control of circulation in pigs. Pflugers Arch 2000; 439:489-494.
10. Lindley TE, Doobay M F, Sharma RV, Davisson RL. Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure. Circ Res 2004; 94:402-409.
11. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 2002; 91:1038-1045.
12. Ohtsuki T, Matsumoto M, Suzuki K, Taniguchi N, Kamada T. Mitochondrial lipid peroxidation and superoxide dismutase in rat hypertensive target organs. Am J Physiol 1995; 268:H1418-H1421.
13. Kimoto-Kinoshita S, Nishida S, Tomura TT. Age-related change of antioxidant capacities in the cerebral cortex and hippocampus of stroke-prone spontaneously hypertensive rats. Neurosci Lett 1999; 273:41-44.
14. Hirooka Y. Role of reactive oxygen species in brainstem in neural mechanisms of hypertension. Auton Neurosci 2008; 142:20-24.
15. Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74:323-364.
16. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 2004; 109:2357-2362.
17. Xu H, Fink GD, Galligan JJ. Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am J Physiol Heart Circ Physiol 2002; 283:H885-H892.
18. Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M, Abe Y. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 2003; 41:266-273.
19. Shokoji T, Fujisawa Y, Kimura S, Rahman M, Kiyomoto H, Matsubara K, Moriwaki K, Aki Y, Miyatake A, Kohno M, Abe Y, Nishiyama A. Effects of local administrations of tempol and diethyldithio-carbamic on peripheral nerve activity. Hypertension 2004; 44:236-243.
20. Chen X, Patel K, Connors SG, Mendonca M, Welch WJ, Wilcox CS. Acute antihypertensive action of Tempol in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2007; 293:H3246-H3253.
21. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ Res 2004; 95:937-944.
22. Pechánová O, Dobesová Z, Cejka J, Kunes J, Zicha J. Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase. J Hypertens 2004; 22:167-173.
23. Wangensteen R, Rodriguez-Gomez I, Moreno JM, Alvarez-Guerra M, Osuna A, Vargas F. Effects of chronic treatment with 7-nitroindazole in hyperthyroid rats. Am J Physiol Regul Integr Comp Physiol 2006; 291:R1376-R1382.
24. Calamandrei G, Venerosi A P, Valanzano A, de Berardinis MA, Greco A, Puopolo M, Minghetti L. Increased brain levels of F2-isoprostane are an early marker of behavioral sequels in a rat model of global perinatal asphyxia. Pediatr Res 2004; 55:85-92.
25. Ganafa AA, Socci RR, Eatman D, Silvestrova N, Abukhalaf IK, Bayorh MA. Acute inhibition of glutathione biosynthesis alters endothelial function and blood pressure in rats. Eur J Pharmacol 2002; 454:217-223.
26. Ford RJ, Graham DA, Denniss SG, Quadrilatero J, Rush JW. Glutathione depletion in vivo enhances contraction and attenuates endothelium-dependent relaxation of isolated rat aorta. Free Radic Biol Med 2006; 40:670-678.
27. Bayorh MA, Ganafa AA, Socci RR, Eatman D, Silvestrov N, Abukhalaf IK. Effect of losartan on oxidative stress-induced hypertension in Sprague-Dawley rats. Am J Hypertens 2003; 16:387-392.
28. Banday AA, Fazili FR, Lokhandwala MF. Oxidative stress causes renal dopamine D1 receptor dysfunction and hypertension via mechanisms that involve nuclear factor-κB and protein kinase C. J Am Soc Nephrol 2007; 18:1446-1457.
29. Zhou XJ, Vaziri ND, Wang XQ, Silva FG, Laszik Z. Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase. J Pharmacol Exp Ther 2002; 300:762-767.
30. Kishi T, Hirooka Y, Mukai Y, Shimokawa H, Takeshita A. Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats. J Hypertens 2003; 21:379-386.
31. Araki S, Hirooka Y, Kishi T, Yasukawa K, Utsumi H, Sunagawa K. Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method. Hypertens Res 2009; 32:1091-1096.
32. Chan SH, Wu CA, Wu KL, Ho YH, Chang AY, Chan JY. Transcriptional upregulation of mitochondrial uncoupling protein 2 protects against oxidative stress-associated neurogenic hypertension. Circ Res 2009; 105:886-896.
33. Vargas F, Moreno JM, Rodríguez-Gómez I, Wangensteen R, Osuna A, Alvarez-Guerra M, García-Estañ J. Vascular and renal function in experimental thyroid disorders. Eur J Endocrinol 2006; 154:197-212.
34. Kolo LL, Westfall TC, Macarthur H. Nitric oxide decreases the biological activity of norepinephrine resulting in altered vascular tone in the rat mesenteric arterial bed. Am J Physiol Heart Circ Physiol 2004; 286:H296-H303.
35. Roberts LJ, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28:505-513.
36. Johns C, Gavras I, Handy DE, Salomao A, Gavras H. Models of experimental hypertension in mice. Hypertension 1996; 28:1064-1069.
37. Bizzozero OA, Reyes S, Ziegler J, Smerjac S. Lipid peroxidation scavengers prevent the carbonylation of cytoskeletal brain proteins induced by glutathione depletion. Neurochem Res 2007; 32:2114-2122.